Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
detroit blog main
detroit top stories
fda
gene therapy
glaxosmithkline
2
×
indiana blog main
indiana top stories
ipo
2
×
life sciences
medical devices
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
2025
abbvie
ad-comm
affimed
What
bio
2
×
roundup
allogene
august
biotech
busy
cancer
crispr
days
decisions
devices
diversity
drugs
fda
hot
immunotherapy
investors
ipo
juno
legacy
million
nearly
new
news
nods
opioid
past
regulatory
remains
sarepta’s
seven
shares
shkreli’s
slow
snapped
stumble
suits
tends
therapeutics
ticket
Language
unset
Current search:
glaxosmithkline
×
bio
×
ipo
×
biogen
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
